9:22 AM
Leo Group India
| ||
| Cosmo Pharmaceuticals Falls Most Since 2009 Bloomberg Cosmo Pharmaceutical SpA (COPN), the Italian developer of treatments for digestive-tract infections, fell the most in almost three years in Zurich after Dutch regulators declined to approve its drug for inflammatory bowel disease. Holland's Medicine Evaluation ... See all stories on this topic » | ||
| Freebies from pharma companies to doctors to be taxable The Hindu Coming down heavily on pharmaceutical and allied health sector industries, the Income Tax Department has in a circular said that it will tax the amount spent by these companies on "providing freebies to medical practitioners and their professional ... See all stories on this topic » | ||
| Pharmaceutical companies spends $30m wining, dining doctors The Australian Australia's $22 billion pharmaceutical industry is sponsoring nurses to work free in doctors' surgeries as "diabetes educators", and to show asthmatics how to use their inhalers. Medicines Australia chief executive Brendan Shaw said yesterday the industry's ... See all stories on this topic » | ||
| Sagent Pharmaceuticals Reports Second Quarter 2012 Financial Results NASDAQ 9, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced financial results for the quarter ended June 30, 2012. Second Quarter ... See all stories on this topic » | ||
| Progenics Pharmaceuticals Announces Second Quarter 2012 Financial Results NASDAQ 9, 2012 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced its results of operations for the second quarter and six months ended June 30, 2012. Net loss for the quarter was $10.7 million or $0.32 basic and diluted per ... See all stories on this topic » | ||
| 5 Pharmaceutical Companies With PDUFA Dates In Q1/2013 Seeking Alpha Pharmaceutical companies with set PDUFA dates usually have a runup leading into the action date. I usually try to buy the stocks 3-9 months before the PDUFA date to make profit from the runup. I screened for companies that have a PDUFA date set during ... See all stories on this topic » | ||
| Sunesis Pharmaceuticals Reports Second Quarter 2012 Financial Results and ... Equities.com 9, 2012 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the quarter ended June 30, 2012. Net loss for the three and six months ended June 30, 2012 was $8.6 million and $22.5 million, respectively. See all stories on this topic » | ||
| Sun Pharma Q1 net profit seen up 31% to Rs 654 cr Moneycontrol.com Sun Pharmaceutical Industries, one of the India's largest drug manufacturers by market value, is set to announce its results for the quarter ended June 2012 on Friday. Analysts on an average expect the consolidated net profit to grow by 30.58% year-on-year ... See all stories on this topic » | ||
| Jazz Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript Seeking Alpha Welcome to the Jazz Pharmaceuticals second quarter 2012 financial results conference call. We reported financial results in a press release issued earlier today. The release is available in the News & Events section on our company website. Among other ... See all stories on this topic » | ||
| Uniform pharma marketing practices code being finalised: Jena Financial Express The Department of Pharmaceuticals (DoP) has prepared a draft Uniform Code of Pharmaceutical Marketing Practices (UCPMP) which is to be adopted voluntarily in the first instance, Minister of State for Chemicals and Fertilizers Srikant Kumar Jena said in a ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment